Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia
Schizophrenia is a neuropsychiatric illness characterized by altered neurotransmission, in which adenosine, a modulator of glutamate and dopamine, plays a critical role that is relatively unexplored in the human brain. In the present study, postmortem human brain tissue from the anterior cingulate c...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/13/19/1657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850283826047090688 |
|---|---|
| author | Smita Sahay Emily A. Devine Christina F.-A. Vargas Robert E. McCullumsmith Sinead M. O’Donovan |
| author_facet | Smita Sahay Emily A. Devine Christina F.-A. Vargas Robert E. McCullumsmith Sinead M. O’Donovan |
| author_sort | Smita Sahay |
| collection | DOAJ |
| description | Schizophrenia is a neuropsychiatric illness characterized by altered neurotransmission, in which adenosine, a modulator of glutamate and dopamine, plays a critical role that is relatively unexplored in the human brain. In the present study, postmortem human brain tissue from the anterior cingulate cortex (ACC) of individuals with schizophrenia (<i>n</i> = 20) and sex- and age-matched control subjects without psychiatric illness (<i>n</i> = 20) was obtained from the Bronx–Mount Sinai NIH Brain and Tissue Repository. Enriched populations of ACC pyramidal neurons were isolated using laser microdissection (LMD). The mRNA expression levels of six key adenosine pathway components—adenosine kinase (ADK), equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2), ectonucleoside triphosphate diphosphohydrolases 1 and 3 (ENTPD1 and ENTPD3), and ecto-5′-nucleotidase (NT5E)—were quantified using real-time PCR (qPCR) in neurons from these individuals. No significant mRNA expression differences were observed between the schizophrenia and control groups (<i>p</i> > 0.05). However, a significant sex difference was found in ADK mRNA expression, with higher levels in male compared with female subjects (Mann–Whitney U = 86; <i>p</i> < 0.05), a finding significantly driven by disease (t<sub>(17)</sub> = 3.289; <i>p <</i> 0.05). Correlation analyses also demonstrated significant associations (<i>n</i> = 12) between the expression of several adenosine pathway components (<i>p</i> < 0.05). In our dementia severity analysis, ENTPD1 mRNA expression was significantly higher in males in the “mild” clinical dementia rating (CDR) bin compared with males in the “none” CDR bin (F<sub>(2, 13)</sub> = 5.212; <i>p < 0.05</i>). Lastly, antipsychotic analysis revealed no significant impact on the expression of adenosine pathway components between medicated and non-medicated schizophrenia subjects (<i>p</i> > 0.05). The observed sex-specific variations and inter-component correlations highlight the value of investigating sex differences in disease and contribute to the molecular basis of schizophrenia’s pathology. |
| format | Article |
| id | doaj-art-833e0b4929eb46729b2bc3565f62e9f2 |
| institution | OA Journals |
| issn | 2073-4409 |
| language | English |
| publishDate | 2024-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj-art-833e0b4929eb46729b2bc3565f62e9f22025-08-20T01:47:42ZengMDPI AGCells2073-44092024-10-011319165710.3390/cells13191657Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in SchizophreniaSmita Sahay0Emily A. Devine1Christina F.-A. Vargas2Robert E. McCullumsmith3Sinead M. O’Donovan4Department of Neurosciences & Psychiatry, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USADepartment of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USADepartment of Neurosciences & Psychiatry, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USADepartment of Neurosciences & Psychiatry, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USADepartment of Neurosciences & Psychiatry, University of Toledo College of Medicine and Life Sciences, Toledo, OH 43614, USASchizophrenia is a neuropsychiatric illness characterized by altered neurotransmission, in which adenosine, a modulator of glutamate and dopamine, plays a critical role that is relatively unexplored in the human brain. In the present study, postmortem human brain tissue from the anterior cingulate cortex (ACC) of individuals with schizophrenia (<i>n</i> = 20) and sex- and age-matched control subjects without psychiatric illness (<i>n</i> = 20) was obtained from the Bronx–Mount Sinai NIH Brain and Tissue Repository. Enriched populations of ACC pyramidal neurons were isolated using laser microdissection (LMD). The mRNA expression levels of six key adenosine pathway components—adenosine kinase (ADK), equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2), ectonucleoside triphosphate diphosphohydrolases 1 and 3 (ENTPD1 and ENTPD3), and ecto-5′-nucleotidase (NT5E)—were quantified using real-time PCR (qPCR) in neurons from these individuals. No significant mRNA expression differences were observed between the schizophrenia and control groups (<i>p</i> > 0.05). However, a significant sex difference was found in ADK mRNA expression, with higher levels in male compared with female subjects (Mann–Whitney U = 86; <i>p</i> < 0.05), a finding significantly driven by disease (t<sub>(17)</sub> = 3.289; <i>p <</i> 0.05). Correlation analyses also demonstrated significant associations (<i>n</i> = 12) between the expression of several adenosine pathway components (<i>p</i> < 0.05). In our dementia severity analysis, ENTPD1 mRNA expression was significantly higher in males in the “mild” clinical dementia rating (CDR) bin compared with males in the “none” CDR bin (F<sub>(2, 13)</sub> = 5.212; <i>p < 0.05</i>). Lastly, antipsychotic analysis revealed no significant impact on the expression of adenosine pathway components between medicated and non-medicated schizophrenia subjects (<i>p</i> > 0.05). The observed sex-specific variations and inter-component correlations highlight the value of investigating sex differences in disease and contribute to the molecular basis of schizophrenia’s pathology.https://www.mdpi.com/2073-4409/13/19/1657adenosine kinaseequilibrative nucleoside transportersectonucleoside triphosphate diphosphohydrolasesecto-5′-nucleotidasesneuromodulationpyramidal neurons |
| spellingShingle | Smita Sahay Emily A. Devine Christina F.-A. Vargas Robert E. McCullumsmith Sinead M. O’Donovan Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia Cells adenosine kinase equilibrative nucleoside transporters ectonucleoside triphosphate diphosphohydrolases ecto-5′-nucleotidases neuromodulation pyramidal neurons |
| title | Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia |
| title_full | Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia |
| title_fullStr | Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia |
| title_full_unstemmed | Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia |
| title_short | Adenosine Metabolism Pathway Alterations in Frontal Cortical Neurons in Schizophrenia |
| title_sort | adenosine metabolism pathway alterations in frontal cortical neurons in schizophrenia |
| topic | adenosine kinase equilibrative nucleoside transporters ectonucleoside triphosphate diphosphohydrolases ecto-5′-nucleotidases neuromodulation pyramidal neurons |
| url | https://www.mdpi.com/2073-4409/13/19/1657 |
| work_keys_str_mv | AT smitasahay adenosinemetabolismpathwayalterationsinfrontalcorticalneuronsinschizophrenia AT emilyadevine adenosinemetabolismpathwayalterationsinfrontalcorticalneuronsinschizophrenia AT christinafavargas adenosinemetabolismpathwayalterationsinfrontalcorticalneuronsinschizophrenia AT robertemccullumsmith adenosinemetabolismpathwayalterationsinfrontalcorticalneuronsinschizophrenia AT sineadmodonovan adenosinemetabolismpathwayalterationsinfrontalcorticalneuronsinschizophrenia |